Nebius (NBIS) stock swings as Israel AI supercomputer launch hits tape, investors eye contract deadlines
22 January 2026
1 min read

Nebius (NBIS) stock swings as Israel AI supercomputer launch hits tape, investors eye contract deadlines

New York, Jan 22, 2026, 14:43 EST — Regular session

Nebius Group N.V. (NBIS) shares were down about 0.1% at $98.73 in afternoon trade on Thursday, after earlier rising more than 5% in a volatile session. The stock opened at $101.95 and has ranged from $96.97 to $103.93, with roughly 8 million shares traded.

Moves like that matter for a company investors treat as a levered bet on rented graphics processing units (GPUs) — the chips that power AI model training — and on how fast new capacity turns into booked revenue. It does not take much to knock the stock off balance.

Nebius closed at $99.29 on Tuesday, down about 8.7% from its prior close, and ended Wednesday at $98.87, according to Nasdaq historical data. The quick reversal into Thursday’s wide range shows traders are still leaning hard on the same theme, just with less patience. 1

Some of the attention has been on Israel’s new national AI supercomputer, which the country has activated and opened to companies and researchers. The Israel Innovation Authority selected Amsterdam-based Nebius to provide the computing infrastructure, and said it plans to allocate the equivalent of 1,000 Nvidia B200 accelerators, with 70% of the resources aimed at companies and 30% at academia. 2

DataCenterDynamics said the first phase is already live, with 1,000 B200 GPUs available for allocation over the coming weeks. Israel Innovation Authority CEO Dror Bin called the launch “a key step in strengthening Israel’s R&D infrastructure for artificial intelligence,” it reported. 3

The broader tape has been supportive for risk assets. Data showed November’s personal consumption expenditures (PCE) price index — the Federal Reserve’s preferred inflation gauge — rose 2.8% from a year earlier, while markets also reacted to signs of easing tariff pressure from President Donald Trump. 4

Behind the day-to-day swings is a longer story about locked-in demand. A September 2025 SEC filing described a five-year agreement to supply Microsoft with dedicated GPU infrastructure from a new Vineland, New Jersey data center, valuing the contract at about $17.4 billion, with an option that could lift it to about $19.4 billion. Chief executive Arkady Volozh said at the time the contract would “help us to accelerate the growth of our AI cloud business.”

But the deal flow cuts both ways if delivery slips. A Nov. 12 SEC filing described a roughly $2.9 billion, five-year deal to supply Meta Platforms with GPU clusters in two tranches — one in December 2025 and another in February 2026 — and said Meta can terminate the second tranche if Nebius misses delivery deadlines. Reuters has also reported Nebius’ losses widened as capital spending surged in its last reported quarter, underscoring the cost of building out capacity fast. 5

The next fixed point for traders is the company’s next results update. Market calendars estimate Nebius will report around Wednesday, Feb. 18, 2026, though the company has not confirmed a date. 6

Stock Market Today

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

7 February 2026
New York, Feb 7, 2026, 09:35 EST — Market closed. Roivant Sciences Ltd shares leapt on Friday after the company reported positive mid-stage results for its immune-modulating drug brepocitinib in a rare skin disease, and paired the readout with its quarterly financial update. The Nasdaq-listed stock closed up 22.4% at $25.82, leaving traders to gauge whether the move has legs when U.S. markets reopen on Monday, Feb. 9. It matters because Roivant is trying to turn a late-stage pipeline into approvals, and the market has been quick to reward biotechs that can show clean efficacy in controlled trials. The company
Amazon stock tumbles on $200 billion AI spend plan — what to know before Monday

Amazon stock tumbles on $200 billion AI spend plan — what to know before Monday

7 February 2026
Amazon shares fell 5.6% to $210.32 on Friday after the company projected about $200 billion in 2026 capital expenditures, triggering investor concern over AI spending. The stock had already dropped 11.5% after-hours Thursday. Amazon forecast Q1 net sales of $173.5–$178.5 billion and operating income of $16.5–$21.5 billion. Analyst Gil Luria downgraded Amazon, citing rising investment as its cloud lead narrows.
AMD stock jumps 8% in chip rebound — what investors are watching before Monday

AMD stock jumps 8% in chip rebound — what investors are watching before Monday

7 February 2026
AMD shares jumped 8.2% to $208.44 Friday, trading on heavy volume as chip stocks rebounded and the Dow closed above 50,000 for the first time. The Philadelphia Semiconductor Index rose 5.7% after Amazon’s AI spending plans lifted sector estimates. Nvidia’s CEO cited surging AI chip demand. AMD’s rally followed a weak revenue outlook earlier in the week.
Why Carvana stock is jumping today: Barclays target raise puts Feb. 18 earnings in view
Previous Story

Why Carvana stock is jumping today: Barclays target raise puts Feb. 18 earnings in view

AST SpaceMobile stock jumps as Blue Origin lines up late-February New Glenn launch for BlueBird 7
Next Story

AST SpaceMobile stock jumps as Blue Origin lines up late-February New Glenn launch for BlueBird 7

Go toTop